A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas
Clinical trial NCT06028373 · TERMINATED
Trial details
- NCT number
- NCT06028373
- Sponsor
- Antengene Biologics Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-08
- Primary completion
- 2026-04-08
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.